An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa

Table 1 Patient demographics and baseline characteristics (N = 17)

Data are expressed as mean (SD) unless indicated otherwise
BMI body mass index, FEV₁ forced expiratory volume in 1 second, LCI lung clearance index, SD standard deviation

ISSN: 1471-2466